Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$0.67 - $1.51 $402,000 - $906,000
-600,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$0.75 - $1.1 $450,000 - $660,000
600,000 New
600,000 $465,000
Q3 2020

Nov 12, 2020

SELL
$0.67 - $0.96 $50,250 - $72,000
-75,000 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$0.52 - $0.92 $39,000 - $69,000
75,000 New
75,000 $57,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.